Feb 3, 2026
What trial designs (endpoints, biomarkers, dosing) have experts recommended for testing dietary bioactives in Alzheimer’s disease patients?
Experts recommend testing dietary bioactives in Alzheimer’s disease (AD) with randomized, often multi‑domain designs that pair clinical cognitive endpoints with structural and molecular biomarkers, lo...